Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT04996706
- Status
- Enrolling By Invitation
Conditions
- Lymphoma, Non-Hodgkin
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this infrastructure protocol is to build and maintain a large and diverse observational cohort study to support broad and cutting-edge research focused on NHL prognosis and survivorship. The LEO cohort will promote identification of clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors that impact multiple outcomes (including event-free, overall and lymphoma-specific survival; new onset comorbidities; and patient-reported outcomes). This resource also will allow examination of the interaction among these factors in order to better understand the clinical and molecular epidemiology of outcomes in NHL. Ultimately, this approach will drive discovery and validation of treatment endpoints, improve prognostication, and identify novel approaches to improve short and long-term outcomes for NHL patients.
Key Dates
- Start date
- Aug 16, 2021
- Status verified
- May 2026
- Primary completion
- Mar 31, 2031
- Completion
- Mar 31, 2031
Study Design
- Enrollment
- 21,000 participants (estimated)
Primary Outcome Measure
Overall Survival (OS) [ Time Frame: Time Frame: Short (<5 years), medium (5-10 years), and long-term (>10 years) ]
Locations (12)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | - |
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | - |
| University of Miami: Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | - |
| Emory St. Joseph's Hospital | Atlanta | Georgia | 30342 | - |
| Emory University Hospital Midtown | Atlanta | Georgia | 30308 | - |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | - |
| University of Iowa | Iowa City | Iowa | 52242 | - |
| Mayo Clinic | Rochester | Minnesota | 55902 | - |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110 | - |
| Weill Cornell Medical College | New York | New York | 10065 | - |
| University of Rochester Medical Center | Rochester | New York | 14642 | - |
| MD Anderson Cancer Center | Houston | Texas | 77030 | - |
Find similar trials in Scottsdale, AZ
Related Studies
- Family Study of Lymphoproliferative DisordersRecruiting · Mayo Clinic · Rochester, Minnesota
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPHASE2 · Recruiting · American Society of Clinical Oncology · Birmingham, Alabama
- Long-Term Follow-up StudyEnrolling By Invitation · Caribou Biosciences, Inc. · Birmingham, Alabama
- A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaPHASE1/PHASE2 · Recruiting · Janssen Research & Development, LLC · Duarte, California